Study Validates Cervical Sample Test for Endometrial Cancer Detection
The DNA-based test showed 96.8% specificity in cervical samples and could help physicians determine which patients need further testing for endometrial cancer.
Read MorePosted by CLP Edit Staff | Oct 15, 2026 | Cancer, Cytology, Womens Health |
The DNA-based test showed 96.8% specificity in cervical samples and could help physicians determine which patients need further testing for endometrial cancer.
Read MorePosted by CLP Edit Staff | Oct 14, 2026 | Dementias & Alzheimer’s, Diagnostic Technologies |
A study of more than 15,000 adults found that the blood biomarker remained consistently associated with brain amyloid despite differences in baseline levels across racial and ethnic groups.
Read MorePosted by CLP Edit Staff | Oct 14, 2026 | Diabetes & Metabolic Diseases, Diagnostic Technologies, Molecular Diagnostics |
A multicenter study led by Children’s Hospital Colorado finds that skin biopsy fibroblast assays can help diagnose primary mitochondrial diseases, potentially reducing the need for invasive muscle and liver biopsies.
Read MorePosted by CLP Edit Staff | Oct 13, 2026 | Cancer, Histology |
Castle Biosciences’ new data presented at ACG 2026 show the TissueCypher test offers objective risk stratification for Barrett’s esophagus progression, providing information beyond standard histopathology.
Read MorePosted by CLP Edit Staff | Oct 13, 2026 | Cardiovascular, Diabetes & Metabolic Diseases |
Labcorp and Thrive Global have launched the Thrive 5 Health Test, a direct-to-consumer panel combining five cardiometabolic biomarkers with behavioral guidance, now available through Labcorp OnDemand.
Read More